CareDx, Inc. (CDNA) Financial Statements
Industry: Medical Laboratories (Services)
In fiscal 2025, CareDx reported revenue of $379.8M, up 13.8% from $333.8M the year before. Net income was -$21.4M (a -5.6% net margin), or -$0.40 per diluted share. Gross margin was 94.0% and operating margin was -8.1%. Operating activities generated $42.0M of cash. At fiscal year end, CareDx held $413.2M in total assets against $110.1M in total liabilities, including $65.4M of cash and equivalents.
Open the full interactive CareDx financials → Quarterly statements, key ratios, valuation history and price charts.
CareDx Key Stats
| Share Price | $65.43 |
|---|---|
| Market Cap | $3.50B |
| Revenue YoY Growth | +13.8% |
| 52-Week Range | $14.28 – $69.85 |
| Shares Outstanding | 51.5 million (basic, 2026 Q2) |
CareDx Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $192.2M | $296.4M | $321.8M | $280.3M | $333.8M | $379.8M |
| Cost of Goods Sold | $13.8M | $18.9M | $17.6M | $18.4M | $23.4M | $23.0M |
| Gross Profit | $178.3M | $277.5M | $304.2M | $261.9M | $310.4M | $356.9M |
| Operating Income | -$22.5M | -$29.7M | -$77.2M | -$203.4M | $40.8M | -$30.8M |
| Pre-Tax Income | -$19.8M | -$32.1M | -$76.2M | -$190.1M | $52.9M | -$21.1M |
| Income Tax | -$1.0M | -$1.4M | $379,000 | $141,000 | $310,000 | $271,000 |
| Net Income | -$18.7M | -$30.7M | -$76.6M | -$190.3M | $52.5M | -$21.4M |
| Diluted EPS | -$0.40 | -$0.59 | -$1.44 | -$3.54 | $0.93 | -$0.40 |
CareDx Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $100.1M | $108.4M | $117.7M | $131.9M |
| Net Income | $1.7M | -$4.1M | $2.8M | $110.6M |
| Diluted EPS | $0.03 | -$0.08 | $0.05 | $2.07 |
CareDx Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $134.7M | $348.5M | $89.9M | $82.2M | $114.7M | $65.4M |
| Current Assets | $273.1M | $433.4M | $387.8M | $313.7M | $351.8M | $257.1M |
| Total Assets | $368.5M | $566.6M | $543.0M | $466.8M | $491.1M | $413.2M |
| Current Liabilities | $69.2M | $77.3M | $76.0M | $78.1M | $89.4M | $89.8M |
| Total Liabilities | $90.8M | $100.7M | $112.1M | $205.5M | $112.6M | $110.1M |
| Shareholders' Equity | $277.7M | $465.9M | $430.9M | $261.3M | $378.4M | $303.1M |
CareDx Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $33.4M | -$19.3M | -$25.2M | -$18.4M | $38.0M | $42.0M |
| Cash From Investing | -$100.4M | $47.7M | -$228.5M | $40.4M | -$483,000 | $2.2M |
| Cash From Financing | $163.1M | $185.6M | -$4.5M | -$29.6M | -$5.6M | -$93.4M |
Figures from CareDx's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full CareDx financials page for every line item.
CareDx Company Profile
| Ticker | CDNA |
|---|---|
| Exchange | Nasdaq |
| Industry | Medical Laboratories (Services) |
| Headquarters | Brisbane, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001217234 |
Frequently Asked Questions
What was CareDx's revenue in fiscal 2025?
CareDx (CDNA) reported revenue of $379.8M for fiscal 2025.
What is CareDx's annual revenue history?
CareDx's annual revenue by fiscal year: 2020: $192.2M; 2021: $296.4M; 2022: $321.8M; 2023: $280.3M; 2024: $333.8M; 2025: $379.8M.
What was CareDx's net income in fiscal 2025?
CareDx reported net income of -$21.4M for fiscal 2025.
What was CareDx's earnings per share (EPS) in fiscal 2025?
CareDx's diluted EPS was -$0.40 for fiscal 2025 (adjusted for any later stock splits).
What was CareDx's revenue last quarter?
In its most recent reported quarter (2026 Q2), CareDx reported revenue of $131.9M.
How many shares of CareDx are outstanding?
CareDx reported a weighted average of 51.5 million basic shares outstanding in 2026 Q2.
What is CareDx's market cap?
Based on its latest closing price, CareDx (CDNA) has a market capitalization of about $3.50B.
When does CareDx's fiscal year end?
CareDx's fiscal year end, as registered with the SEC, is December 31.
Where is CareDx headquartered?
CareDx lists its business address in Brisbane, California in its SEC filings.